Rare-29. high-dose methotrexate (hd mtx)-based treatments of primary cns lymphoma: optimal dose revisited - a retrospective analysis of outcomes in tertiary medical center

CONCLUSION:Treatment with HD MTX at the dose of 8 g/m2improved response rates, OS and PFS in patients with PCNSL after 12, 36 and 60 months, compared with treatment at lower MTX doses.

Source: Neuro-Oncology - November 6, 2016 Category: Cancer & Oncology Authors: Bainhoren, O. A., Asna, N., Mendel, L., Blumenthal, D. T., Bokstein, F. Tags: RARE TUMORS Source Type: research